168 related articles for article (PubMed ID: 8270269)
1. Recombinant viral vaccines for enzootic bovine leucosis.
Daniel RC; Gatei MH; Good MF; Boyle DB; Lavin MF
Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():399-404. PubMed ID: 8270269
[TBL] [Abstract][Full Text] [Related]
2. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
3. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
[TBL] [Abstract][Full Text] [Related]
4. Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes.
Cherney TM; Schultz RD
Am J Vet Res; 1996 Jun; 57(6):812-8. PubMed ID: 8725805
[TBL] [Abstract][Full Text] [Related]
5. Protection of cattle against bovine leukemia virus (BLV) infection could be attained by DNA vaccination.
Brillowska A; Dabrowski S; Rułka J; Kubiś P; Buzała E; Kur J
Acta Biochim Pol; 1999; 46(4):971-6. PubMed ID: 10824867
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: their role in the suppression of BLV replication.
Ohishi K; Suzuki H; Yasutomi Y; Onuma M; Okada K; Numakunai S; Ohshima K; Ikawa Y; Sugimoto M
Microbiol Immunol; 1992; 36(12):1317-23. PubMed ID: 1337572
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.
Ohishi K; Suzuki H; Yamamoto T; Maruyama T; Miki K; Ikawa Y; Numakunai S; Okada K; Ohshima K; Sugimoto M
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1887-92. PubMed ID: 1651982
[TBL] [Abstract][Full Text] [Related]
8. Role of cell-mediated immunity in bovine leukemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses.
Sugimoto M; Ohishi K; Ikawa Y
Ther Immunol; 1994 Oct; 1(5):297-301. PubMed ID: 7584504
[TBL] [Abstract][Full Text] [Related]
9. [Protective effect against BLV by inoculation with a vaccinia virus-BLV env recombinant].
Ohishi K
Uirusu; 1992 Dec; 42(2):155-70. PubMed ID: 1338242
[No Abstract] [Full Text] [Related]
10. Agar gel immunodiffusion analysis using baculovirus-expressed recombinant bovine leukemia virus envelope glycoprotein (gp51/gp30(T-)).
Lim SI; Jeong W; Tark DS; Yang DK; Kweon CH
J Vet Sci; 2009 Dec; 10(4):331-6. PubMed ID: 19934599
[TBL] [Abstract][Full Text] [Related]
11. Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity.
Ohishi K; Kabeya H; Amanuma H; Onuma M
Leukemia; 1997 Apr; 11 Suppl 3():223-6. PubMed ID: 9209348
[TBL] [Abstract][Full Text] [Related]
12. Long-term protection against bovine leukaemia virus replication in cattle and sheep.
Kerkhofs P; Gatot JS; Knapen K; Mammerickx M; Burny A; Portetelle D; Willems L; Kettmann R
J Gen Virol; 2000 Apr; 81(Pt 4):957-63. PubMed ID: 10725421
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of tumor necrosis factor alpha mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection.
Kabeya H; Ohashi K; Oyunbileg N; Nagaoka Y; Aida Y; Sugimoto C; Yokomizo Y; Onuma M
Vet Immunol Immunopathol; 1999 May; 68(2-4):255-65. PubMed ID: 10438324
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
Bai L; Otsuki H; Sato H; Kohara J; Isogai E; Takeshima SN; Aida Y
Retrovirology; 2015 Dec; 12():106. PubMed ID: 26715158
[TBL] [Abstract][Full Text] [Related]
15. gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host.
Lundberg P; Splitter GA
J Virol; 2000 Sep; 74(18):8299-306. PubMed ID: 10954528
[TBL] [Abstract][Full Text] [Related]
16. Development of a specific serological test and an efficient subunit vaccine to control bovine leukemia virus infection.
Portetelle D; Burny A; Desmettre P; Mammerickx M; Paoletti E; Zavada J
Dev Biol Stand; 1990; 72():81-90. PubMed ID: 1704325
[TBL] [Abstract][Full Text] [Related]
17. Reduced humoral immunity and atypical cell-mediated immunity in response to vaccination in cows naturally infected with bovine leukemia virus.
Frie MC; Sporer KR; Wallace JC; Maes RK; Sordillo LM; Bartlett PC; Coussens PM
Vet Immunol Immunopathol; 2016 Dec; 182():125-135. PubMed ID: 27863543
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CD8+ T cells in delayed-type hypersensitivity responses against bovine leukemia virus (BLV) induced in sheep vaccinated with recombinant vaccinia virus expressing BLV envelope glycoprotein.
Okada K; Ikeyama S; Ohishi K; Suzuki H; Sugimoto M; Numakunai S; Chiba T; Murakami K; Davis WC; Ohshima K
Vet Pathol; 1993 Mar; 30(2):104-10. PubMed ID: 8470333
[TBL] [Abstract][Full Text] [Related]
19. Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine.
Altaner C; Ban J; Altanerova V; Janik V
Vaccine; 1991 Dec; 9(12):889-95. PubMed ID: 1667347
[TBL] [Abstract][Full Text] [Related]
20. Protection by vaccination against bovine leukemia virus infection in sheep.
Onuma M; Hodatsu T; Yamamoto S; Higashihara M; Masu S; Mikami T; Izawa H
Am J Vet Res; 1984 Jun; 45(6):1212-5. PubMed ID: 6331233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
